Metro Hospitals and Heart Institute

Details Associates Doctors
Medical Suppliers In Haryana

Name :

Metro Hospitals and Heart Institute

Address  :

H - Block,
Palam Vihar

Town  :

Gurgaon

State  :

Haryana

Country  :

INDIA

Post Code:

122017

Phone  :

0124-4777000

Fax  :

0124-4777099

Web URL  :

Available

Email  :

metropalamvihar@metrohospitals.com
Metro Hospitals and Heart Institute

Doctors Of Metro Hospitals and Heart Institute
Physician
Qualification
Availability
Dr. (Col.) Shishir Kumar
Resident
Dr Akash Yadav
MBBS, MD, Dcard, MIACC, FICR
Resident
Dr Anu Sidana
MBSS, DGO, DNB - Gynaecology
Resident
Dr Arun Duggal
MBBS,DCH,FIAMS
Resident
Dr Ashu Consul
MBBS, MS (Orthpaedics), MCh
Resident
Dr Atul Prakash
MBBS,MS(Ortho), DNB Ortho Surgery),FRCS,MN AMS(Ortho Surgery)
Resident
Dr Harmeet Singh Pasricha
MBSS, DNB-ENT
Resident
Dr Jawahar Ticku
MBBS,MD
On Visit
Dr Jyoti Sharma
MBBS, DGO
Resident
Dr Kiran Kaur
MBBS, MS(Ophthalmology)
Resident
Dr Manish Mishra
MBBS, MD, Dcard, MIACC, FICR
Resident
Dr Pallavee Goswami
MBBS, MS(Ophthalmolog y) 11.30-1pm
Resident
Dr S K Dham
MBBS, MD(Internal Medicine), Msc(Immunology)
Resident
Dr Sangeeta Verma
MBBS, DNB - Dermatology, M. Derm
Resident
Dr Sanyukta Phukan Banerjee
MBBS; D.M.R.D;MD(Radio Diag. & Imag.)
Resident
Dr Sarwar Iqbal
MBBS, MS (Gen. Surgery), DNB (Genito-Uro Surgery)
Resident
Dr Saurabh Ghai
BDS
Resident
Dr Sharmila Solanki
MBBS, MD (Obs & Gynae)
Resident
DR Vivek Aggarwal
MBBS, MD - Medicine, DM - Cardiology, FSCAI
Resident
Dr Vivek Nair
MBBS, MD, Dermatology, V & L
Resident
NEWS
Kovai Medical Center and Hospital signs MoU with Global hospitals

COIMBATORE The liver transplantation scene in India that started with low success rates a few decades ago has evolved into a specialty that boasts success and survival rates comparable with the best centers in the world said K Ravindranath chairman and managing director Global Hospital group Apart from medical expertise and technological advanc... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More